RT 20MG
£180.00
Skip to product information
RT 20MG
£180.00
RTA
A triple-receptor agonist researched for its potential effects on appetite regulation, glucose metabolism, and body-weight reduction. It simultaneously targets GLP-1, GIP, and glucagon receptors, making it an area of research in metabolic and obesity-related studies. Recent clinical research has reported reductions in body weight and improvements in glycaemic measures, but it remains investigational.
FOR RESEARCH PURPOSES ONLY
